ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Charles C. Canver
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canver, C. C.
Right arrow Articles by Chanda, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canver, C. C.
Right arrow Articles by Chanda, J.
Related Collections
Right arrow Transplantation - heart

Ann Thorac Surg 2001;72:658-660
© 2001 The Society of Thoracic Surgeons

Key references

Heart transplantation

Charles C. Canver, MDa, Jyotirmay Chanda, MD, PhDa

a Division of Cardiothoracic Surgery, Albany Medical College, Albany, New York, USA

Address reprint requests to Dr Canver, Division of Cardiothoracic Surgery, Mail Code 55, Albany Medical College, 47 New Scotland Ave, Albany, NY 12208
e-mail: canverc{at}mail.amc.edu

History of heart transplantation

  1. Barnard C.N. A human cardiac transplant: an interim report of a successful operation performed at Groote Shuur Hospital, Capetown. S Afr Med J 1967;41:1271-1274.[Medline]
  2. Kantrowitz A. America’s first heart transplantation: the concept, the planning, the furor. ASAIO J 1998;44:244-251.[Medline]
  3. Rodeheffer R.J., McGregor C.G. The development of cardiac transplantation. Mayo Clin Proc 1992;67:480-484.[Medline]
  4. Patterson C., Patterson K.B. The history of heart transplantation. Am J Med Sci 1997;314:190-197.[Medline]
Selection of heart transplant recipients

  1. http://www.unos.org/frame_Default.asp?Category=About
  2. Miller L.W. Listing criteria for cardiac transplantation. Transplantation 1998;66:947-951.[Medline]
  3. Mudge G.H., Goldstein S., Addonizio L.Z., et al. 24th Bethesda conference on cardiac transplantation: Task Force 3: recipient guidelines. J Am Coll Cardiol 1993;22:21-30.[Medline]
  4. Torre-Amione G., Kapadia S., Short D., et al. Evolving concepts regarding selection of patients for cardiac transplantation: assessing risks and benefits. Chest 1996;109:223-232.[Free Full Text]
  5. Ramos-Barbon D., Fitchett D., Gibbons W.J., Latter D.A., Levy R.D. Maximal exercise testing for the selection of heart transplantation candidates: limitation of peak oxygen consumption. Chest 1999;115:410-417.[Abstract/Free Full Text]
  6. Koelling T.M., Semigran M.J., Mijller-Ehmsen J., et al. Left ventricular end-diastolic volume index, age, and maximum heart rate at peak exercise predict survival in patients referred for heart transplantation. J Heart Lung Trans 1998;17:278-287.[Medline]
  7. Osada N., Chaitman B.R., Miller L.W., et al. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Amer Coll Cardiol 1998;31:577-582.[Abstract/Free Full Text]
Selection of heart transplant donors

  1. Tenderich G., Koerner M.M., Stuettgen B., et al. Extended donor criteria: hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors >= 60 years of age. Transplantation 1998;668:1109-1113.
  2. Baldwin J.C., Anderson J.L., Boucek M.M., et al. 24th Bethesda conference: cardiac transplantation. Task Force 2: donor guidelines. J Amer Coll Cardiol 1993;22:15-20.[Medline]
  3. Anonymous Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA 1981;246:2184-2186.[Abstract/Free Full Text]
  4. Jeevanandam V., Furukawa S., Prendergast T.W., Todd B.A., Eisen H.J., McClurken J.B. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996;62:1268-1275.[Abstract/Free Full Text]
  5. Young J.B., Naftel D.C., Bourge R.C., et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Trans 1994;13:353-364.[Medline]
Management of patients awaiting heart transplantation

  1. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3593-3612.[Abstract/Free Full Text]
  2. Leier C.V., Binkley P.F. Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis 1998;41:207-224.[Medline]
  3. Canver C.C., Chanda J. Milrinone for long-term pharmacologic support of status 1 heart transplant candidates. Ann Thorac Surg 2000;69:1823-1826.[Abstract/Free Full Text]
  4. Bank A.J., Mir S.H., Nguyen D.Q., et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 2000;69:1369-1374.[Abstract/Free Full Text]
  5. El-Banayosy A., Arusoglu L., Kizner L., Tenderich G., Minami K., Inoue K., Korfer R. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000;119:581-587.[Abstract/Free Full Text]
  6. Helman D.N., Morales D.L., Edwards N.M., Mancini D.M., Chen J.M., Rose E.A., Oz M.C. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 1999;68:1187-1194.[Abstract/Free Full Text]
  7. Korfer R., El-Banayosy A., Arusoglu L., et al. Single-center experience with the thoratec ventricular assist device. J Thorac Cardiovasc Surg 2000;119:596-600.[Abstract/Free Full Text]
Organ preservation

  1. Jahania M.S., Sanchez J.A., Narayan P., Lasley R.D., Mentzer R.M., Jr Heart preservation for transplantation: principles and strategies. Ann Thorac Surg 1999;68:1983-1987.[Abstract/Free Full Text]
  2. Stringham J.C., Love R.B., Welter D., Canver C.C., Mentzer R.M., Jr Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation. Circulation 1998;98(19 Suppl):II157-II161.
  3. Demmy T.L., Biddle J.S., Bennett L.E., Walls J.T., Schmaltz R.A., Curtis J.J. Organ preservation solutions in heart transplantation: patterns of usage and related survival. Transplantation 1997;63:262-269.[Medline]
Surgical technique

  1. Lower R.R., Shumway N.E. Studies on the orthotopic homotransplantation of the canine heart. Surg Forum 1960;11:18-19.[Medline]
  2. Blanche C., Czer L.S., Valenza M., Trento A. Alternative technique for orthotopic heart transplantation. Ann Thorac Surg 1994;57:765-767.[Abstract]
  3. Brandt M., Harringer W., Hirt S.W., et al. Influence of bicaval anastomoses on late occurrence of atrial arrhythmia after heart transplantation. Ann Thorac Surg 1997;64:70-72.[Abstract/Free Full Text]
  4. Traversi E., Pozzoli M., Grande A., et al. The bicaval anastomosis technique for orthotopic heart transplantation yields better atrial function than the standard technique: an echocardiographic automatic boundary detection study. J Heart Lung Trans 1998;17:1065-1074.[Medline]
  5. Aziz T., Burgess M., Khafagy R., et al. Bicaval and standard techniques in orthotopic heart transplantation: medium-term experience in cardiac performance and survival. J Thorac Cardiovasc Surg 1999;118:115-122.[Abstract/Free Full Text]
  6. Grande A.M., Rinaldi M., D’Armini A.M., et al. Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol 2000;85:1329-1333.[Medline]
Heterotopic heart transplantation

  1. Kadner A., Chen R.H., Adams D.H. Heterotopic heart transplantation: experimental development and clinical experience. Eur J Cardio-Thorac Surg 2000;17:474-481.[Abstract/Free Full Text]
  2. Tagusari O., Kormos R.L., Kawai A., et al. Native heart complications after heterotopic heart transplantation: insight into the potential risk of left ventricular assist device. J Heart Lung Trans 1999;18:1111-1119.[Medline]
Management of the cardiac transplant recipient

  1. Robbins R.C., Barlow C.W., Oyer P.E., et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999;117:939-951.[Abstract/Free Full Text]
  2. Haverty T.P., Sanders M., Sheahan M. OKT3 treatment of cardiac allograft rejection. J Heart Lung Trans 1993;12:591-598.[Medline]
  3. Park M.H., Starling R.C., Ratliff N.B., et al. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection. J Heart Lung Trans 1999;18:1224-1227.[Medline]
  4. Yamani M.H., Starling R.C., Pelegrin D., et al. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart Lung Trans 2000;19:337-342.[Medline]
  5. Kobashigawa J., Miller L., Renlund D., et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil. Transplantation 1998;66:507-515.[Medline]
  6. Aleksic I., Baryalei M., Busch T., et al. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine. Transplantation 2000;69:1586-1590.[Medline]
  7. Taylor D.O., Barr M.L., Radovancevic B., et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Trans 1999;18:336-345.[Medline]
  8. Pham S.M., Rao A.S., Zeevi A., et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000;119:673-681.[Abstract/Free Full Text]
Diagnosis of rejection

  1. Caves P.K., Stinson E.B., Billingham M.E., et al. Percutaneous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg 1973;16:325-336.[Medline]
  2. Schaffellner S., Grasser B., Kniepeiss D., et al. Noninvasive heart monitoring after heart transplantation with CHARM (computerized heart allograft recipient monitoring): clinical experience. Trans Proc 2000;32:642-644.
  3. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Trans 1997;16:813-821.[Medline]
  4. Ballester M., Bordes R., Tazelaar H.D., et al. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. J Amer Coll Cardiol 1998;31:1357-1361.[Abstract/Free Full Text]
  5. Abdallah A.N., Billes M.A., Attia Y., Doutremepuich C., Cassaigne A., Iron A. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J 1997;18:1024-1029.[Abstract/Free Full Text]
Complications

  1. Thomson J.G. Production of severe atheroma in a transplanted human heart. Lancet 1969;2:1088-1092.[Medline]
  2. Billingham M.E. Cardiac transplant atherosclerosis. Trans Proc 1987;19:19-25.
  3. Miller L.W., Naftel D.C., Bourge R.C., et al. Infection after heart transplantation: a multiinstitutional study. Cardiac transplantation research database group. J Heart Lung Trans 1994;13:381-392.[Medline]
  4. Smart F.W., Naftel D.C., Costanzo M.R., et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Trans 1996;15:329-341.[Medline]
  5. Dent C.L., Canter C.E., Hirsch R., Balzer D.T. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Trans 2000;19:240-248.[Medline]
  6. Kelley M.P., Narula N., Loh E., Acker M.A., Tomaszewski J.E., DeNofrio D. Early post-transplant lymphoproliferative disease following heart transplantation in the absence of lymphocytolytic induction therapy. J Heart Lung Trans 2000;19:805-809.[Medline]
  7. Veness M.J., Quinn D.I., Ong C.S., et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999;85:1758-1764.[Medline]
Survival

  1. 1999 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989–1998. (2000, February 21). Rockville, MD and Richmond, VA: HHS/HRSA/OSP/DOT and UNOS. Retrieved February 21, 2001 from the World Wide Web: http://www.unos.org/Data/anrpt_main.htm
  2. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report—1999. J Heart Lung Trans 1999;18:611-626.[Medline]
  3. John R., Rajasinghe H.A., Itescu S., et al. Factors affecting long-term survival (> 10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol 2001;37:189-194.[Abstract/Free Full Text]
  4. Brann W.M., Bennett L.E., Keck B.M., Hosenpud J.D. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Trans 1998;17:374-382.[Medline]
Xenotransplantation

  1. Platt J.L. Prospects for xenotransplantation. Ped Trans 1999;3:193-200.
  2. DiSesa V.J. Cardiac xenotransplantation. Ann Thorac Surg 1997;64:1858-1865.[Abstract/Free Full Text]
Retransplantation

  1. Srivastava R., Keck B.M., Bennett L.E., Hosenpud J.D. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation 2000;70:606-612.[Medline]
  2. Chan M., Hunt S.A. Heart retransplantation. Cardiol Rev 1998;6:350-355.[Medline]
Pediatric heart transplantation

  1. Rosenthal D.N., Dubin A.M., Chin C., Falco D., Gamberg P., Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Trans 2000;19:751-755.[Medline]
  2. Kanter K.R., Tam V.K., Vincent R.N., Cuadrado A.R., Raviele A.A., Berg A.M. Current results with pediatric heart transplantation. Ann Thorac Surg 1999;68:527-530.[Abstract/Free Full Text]
  3. Shaffer K.M., Denfield S.W., Schowengerdt K.O., et al. Cardiac transplantation for pediatric patients with inoperable congenital heart disease. Tex Heart Inst J 1998;25:57-63.[Medline]
  4. Vricella L.A., Razzouk A.J., Gundry S.R., Larsen R.L., Kuhn M.A., Bailey L.L. Heart transplantation in infants and children with situs inversus. J Thorac Cardiovasc Surg 1998;116:82-89.[Abstract/Free Full Text]
  5. Canter C., Naftel D., Caldwell R., et al. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study. Circulation 1997;96:227-231.[Abstract/Free Full Text]
  6. Schowengerdt K.O., Naftel D.C., Seib P.M., et al. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group. J Heart Lung Trans 1997;16:1207-1216.[Medline]
  7. Khaghani A., Santini F., Dyke C.M., Onuzu O., Radley-Smith R., Yacoub M.H. Heterotopic cardiac transplantation in infants and children. J Thorac Cardiovasc Surg 1997;113:1042-1048.[Abstract/Free Full Text]
  8. Hetzer R., Loebe M., Potapov E.V., et al. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg 1998;66:1498-1506.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
H. Kondoh, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Kitagawa-Sakakida, Y. Imanishi, N. Kawaguchi, N. Matsuura, and H. Matsuda
Combined Strategy Using Myoblasts and Hepatocyte Growth Factor in Dilated Cardiomyopathic Hamsters
Ann. Thorac. Surg., July 1, 2007; 84(1): 134 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. M. Nugent and E. R. Edelman
Tissue Engineering Therapy for Cardiovascular Disease
Circ. Res., May 30, 2003; 92(10): 1068 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Miyagawa, Y. Sawa, S. Taketani, N. Kawaguchi, T. Nakamura, N. Matsuura, and H. Matsuda
Myocardial Regeneration Therapy for Heart Failure: Hepatocyte Growth Factor Enhances the Effect of Cellular Cardiomyoplasty
Circulation, May 28, 2002; 105(21): 2556 - 2561.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Charles C. Canver
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canver, C. C.
Right arrow Articles by Chanda, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canver, C. C.
Right arrow Articles by Chanda, J.
Related Collections
Right arrow Transplantation - heart

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS